These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987 [TBL] [Abstract][Full Text] [Related]
4. Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels. Gonzalez-Mira E; Nikolić S; Calpena AC; Egea MA; Souto EB; García ML J Pharm Sci; 2012 Feb; 101(2):707-25. PubMed ID: 22012873 [TBL] [Abstract][Full Text] [Related]
5. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662 [TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanism. Song A; Su Z; Li S; Han F Drug Dev Ind Pharm; 2015; 41(9):1488-92. PubMed ID: 25231972 [TBL] [Abstract][Full Text] [Related]
7. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Kawadkar J; Pathak A; Kishore R; Chauhan MK Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934 [TBL] [Abstract][Full Text] [Related]
8. Pluronic lecithin organogel as a topical drug delivery system. Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074 [TBL] [Abstract][Full Text] [Related]
9. Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen. Han F; Li S; Yin R; Shi X; Jia Q Drug Dev Ind Pharm; 2008 Apr; 34(4):453-8. PubMed ID: 18401788 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery. Noor NM; Sheikh K; Somavarapu S; Taylor KMG Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472 [TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Nagaich U; Gulati N Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979 [TBL] [Abstract][Full Text] [Related]
12. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability. Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524 [TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam. Khurana S; Jain NK; Bedi PM Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071 [TBL] [Abstract][Full Text] [Related]
15. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation. Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401 [TBL] [Abstract][Full Text] [Related]
16. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application. Nnamani PO; Hansen S; Windbergs M; Lehr CM Int J Pharm; 2014 Dec; 477(1-2):208-17. PubMed ID: 25290810 [TBL] [Abstract][Full Text] [Related]
17. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Abdel-Mottaleb MM; Neumann D; Lamprecht A Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002 [TBL] [Abstract][Full Text] [Related]
18. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin. Sütő B; Berkó S; Kozma G; Kukovecz Á; Budai-Szűcs M; Erős G; Kemény L; Sztojkov-Ivanov A; Gáspár R; Csányi E Int J Nanomedicine; 2016; 11():1201-12. PubMed ID: 27099487 [TBL] [Abstract][Full Text] [Related]
19. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401 [TBL] [Abstract][Full Text] [Related]